Probetex is a pioneering company within the biotechnology industry, dedicated to empowering groundbreaking disease research through its advanced tools and services. Established in 1997, the company's slogan, "Empowering groundbreaking disease research with advanced tools and services for comprehensive evaluation and analysis," encapsulates its mission to revolutionize disease assessment. Probetex offers innovative products and services that are instrumental in disease research, providing sophisticated tools crucial for collecting essential data for publications, grant applications, and drug discovery. The company's contract drug discovery services stand out for their utilization of specialized organ and kidney disease models, including renal function testing, tissue preparation for embedding in paraffin and staining, frozen tissue for immunohistochemistry, image analysis, and tissue lysates for comprehensive analysis. While operational details such as headquarters, last investment, and associated investors were not included, Probetex's commitment to driving innovation in disease research positions it as a compelling prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Probetex Inc.